CBD of Denver Inc. Announces Filing of Q1 Quarterly Disclosure and Financials
Denver, Colorado--(Newsfile Corp. - May 9, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) is pleased to announce the...
Month: May 2024
FendX Technologies Announces Closing of Non-Brokered Private Placement
Oakville, Ontario--(Newsfile Corp. - May 8, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...
FendX Technologies Announces Closing of Non-Brokered Private Placement
Oakville, Ontario--(Newsfile Corp. - May 8, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...
Glow Announces Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - May 8, 2024) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) ("Glow" or the "Company") announces...
Glow Announces Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - May 8, 2024) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) ("Glow" or the "Company") announces...
Neural Therapeutics Receives Conditional Approval to Listing on the CSE and Announces Concurrent Financing
Toronto, Ontario--(Newsfile Corp. - May 8, 2024) - Neural Therapeutics Inc. ("Neural" or the "Company"), an ethnobotanical drug discovery company...
Neural Therapeutics Receives Conditional Approval to Listing on the CSE and Announces Concurrent Financing
Toronto, Ontario--(Newsfile Corp. - May 8, 2024) - Neural Therapeutics Inc. ("Neural" or the "Company"), an ethnobotanical drug discovery company...
Welter Healthcare Partners Earns Prestigious NCQA Credentials Verification Organization (CVO) Certification
Achieving this honor places Welter Healthcare Partners in an elite group of six companies that have achieved the coveted URAC...
Welter Healthcare Partners Earns Prestigious NCQA Credentials Verification Organization (CVO) Certification
Achieving this honor places Welter Healthcare Partners in an elite group of six companies that have achieved the coveted URAC...
Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome (SBS) in Europe
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency...
Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome (SBS) in Europe
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency...
Gilead’s FOCUS Program Helps Zero In on Early HIV Detection
NORTHAMPTON, MA / ACCESSWIRE / May 9, 2024 / A 22-year-old college student who didn't feel well was treated at...
Gilead’s FOCUS Program Helps Zero In on Early HIV Detection
NORTHAMPTON, MA / ACCESSWIRE / May 9, 2024 / A 22-year-old college student who didn't feel well was treated at...
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services
SAN DIEGO, CA / ACCESSWIRE / May 9, 2024 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision medicine for...
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services
SAN DIEGO, CA / ACCESSWIRE / May 9, 2024 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision medicine for...
Hospitals Preparing for Surge of Summer Births With Support From US Med-Equip
HOUSTON, TX / ACCESSWIRE / May 9, 2024 / As hospitals prepare for the summer months, a period traditionally marked...
Hospitals Preparing for Surge of Summer Births With Support From US Med-Equip
HOUSTON, TX / ACCESSWIRE / May 9, 2024 / As hospitals prepare for the summer months, a period traditionally marked...
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
Xifaxan is the first and only FDA approved medication for the reduction in risk of OHE recurrence in adultsOvert Hepatic...
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
Xifaxan is the first and only FDA approved medication for the reduction in risk of OHE recurrence in adultsOvert Hepatic...
Halberd’s Traumatic Brain Injury Treatment Projects Align with New U.S. House Bill
Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, passed the U.S. House unanimously.JACKSON CENTER,...